Exact Mass: 401.24134000000004
Exact Mass Matches: 401.24134000000004
Found 131 metabolites which its exact mass value is equals to given mass value 401.24134000000004
,
within given mass tolerance error 0.01 dalton. Try search metabolite list with more accurate mass tolerance error
0.001 dalton.
6'-Hydroxybuspirone
6-Hydroxybuspirone is a metabolite of buspirone. Buspirone is an anxiolytic psychoactive drug of the azapirone chemical class, and is primarily used to treat generalized anxiety disorder (GAD) Bristol-Myers Squibb (BMS) gained FDA approval of buspirone in 1986 for treatment of GAD. The patent on Buspar by Bristol-Myers Squibb expired in 2001, and buspirone is available as a generic. (Wikipedia)
Buspirone N-oxide
Buspirone N-oxide is a metabolite of buspirone. Buspirone is an anxiolytic psychoactive drug of the azapirone chemical class, and is primarily used to treat generalized anxiety disorder (GAD) Bristol-Myers Squibb (BMS) gained FDA approval of buspirone in 1986 for treatment of GAD. The patent on Buspar by Bristol-Myers Squibb expired in 2001, and buspirone is available as a generic. (Wikipedia)
3'-Hydroxybuspirone
3-Hydroxybuspirone is a metabolite of buspirone. Buspirone is an anxiolytic psychoactive drug of the azapirone chemical class, and is primarily used to treat generalized anxiety disorder (GAD) Bristol-Myers Squibb (BMS) gained FDA approval of buspirone in 1986 for treatment of GAD. The patent on Buspar by Bristol-Myers Squibb expired in 2001, and buspirone is available as a generic. (Wikipedia)
5-Hydroxybuspirone
5-Hydroxybuspirone is a metabolite of buspirone. Buspirone is an anxiolytic psychoactive drug of the azapirone chemical class, and is primarily used to treat generalized anxiety disorder (GAD) Bristol-Myers Squibb (BMS) gained FDA approval of buspirone in 1986 for treatment of GAD. The patent on Buspar by Bristol-Myers Squibb expired in 2001, and buspirone is available as a generic. (Wikipedia)
5-Methylurapidil
D018377 - Neurotransmitter Agents > D018663 - Adrenergic Agents > D018674 - Adrenergic Antagonists
Isoquinoline, 1,2,3,4-tetrahydro-2-(4-amino-6-((4-phenyl-1-piperazinyl)methyl)-s-triazin-2-yl)-
[2-Amino-2-(hydroxymethyl)-5-(4-octylphenyl)pentyl] dihydrogen phosphate
C20H36NO5P (401.23309760000006)
N-Allm
C19H35N3O4S (401.2348150000001)
Ala Gly Arg Val
Ala Gly Val Arg
Ala Arg Gly Val
Ala Arg Val Gly
Ala Val Gly Arg
Ala Val Arg Gly
Gly Ala Arg Val
Gly Ala Val Arg
Gly Gly Ile Arg
Gly Gly Leu Arg
Gly Gly Arg Ile
Gly Gly Arg Leu
Gly Ile Gly Arg
Gly Ile Arg Gly
Gly Leu Gly Arg
Gly Leu Arg Gly
Gly Arg Ala Val
Gly Arg Gly Ile
Gly Arg Gly Leu
Gly Arg Ile Gly
Gly Arg Leu Gly
Gly Arg Val Ala
Gly Val Ala Arg
Gly Val Arg Ala
Ile Gly Gly Arg
Ile Gly Arg Gly
Ile Arg Gly Gly
Leu Gly Gly Arg
Leu Gly Arg Gly
Leu Arg Gly Gly
Arg Ala Gly Val
Arg Ala Val Gly
Arg Gly Ala Val
Arg Gly Gly Ile
Arg Gly Gly Leu
Arg Gly Ile Gly
Arg Gly Leu Gly
Arg Gly Val Ala
Arg Ile Gly Gly
Arg Leu Gly Gly
Arg Val Ala Gly
Arg Val Gly Ala
Val Ala Gly Arg
Val Ala Arg Gly
Val Gly Ala Arg
Val Gly Arg Ala
Val Arg Ala Gly
Val Arg Gly Ala
ALLM (Calpain Inhibitor)
C19H35N3O4S (401.2348150000001)
D004791 - Enzyme Inhibitors > D011480 - Protease Inhibitors > D007976 - Leupeptins
4-(3,4-dihydro-2H-quinolin-1-yl)-6-[(4-phenyl-1-piperazinyl)methyl]-1,3,5-triazin-2-amine
Dehydrocholate
C24H33O5- (401.23278680000004)
D005765 - Gastrointestinal Agents > D002756 - Cholagogues and Choleretics D005765 - Gastrointestinal Agents > D001647 - Bile Acids and Salts D005765 - Gastrointestinal Agents > D002793 - Cholic Acids
ALLM
C19H35N3O4S (401.2348150000001)
D004791 - Enzyme Inhibitors > D011480 - Protease Inhibitors > D015853 - Cysteine Proteinase Inhibitors
[1-(3-Phenoxypropyl)-4-piperidinyl]-diphenylmethanol
1-ethyl-4-hydroxy-2-oxo-N-(1-oxodecyl)-3-quinolinecarbohydrazide
C22H31N3O4 (401.23144460000003)
5,6-dimethyl-2-[1-[[1-(phenylmethyl)-5-tetrazolyl]methyl]-4-piperidinyl]-1H-benzimidazole
1-[2-[[(2,3-dihydro-1H-inden-5-ylamino)-oxomethyl]amino]-2-methyl-1-oxopropyl]-4-piperidinecarboxylic acid ethyl ester
C22H31N3O4 (401.23144460000003)
Crambescidin 401
C22H31N3O4 (401.23144460000003)
An organic heteropentacyclic guanidine alkaloid isolated from the marine sponge Crambe crambe.
(2R,3R)-8-[2-(1-hydroxycyclopentyl)ethynyl]-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-2-(methylaminomethyl)-3,4-dihydro-2H-pyrido[2,3-b][1,5]oxazocin-6-one
C22H31N3O4 (401.23144460000003)
(2R,3S)-8-[2-(1-hydroxycyclopentyl)ethynyl]-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-2-(methylaminomethyl)-3,4-dihydro-2H-pyrido[2,3-b][1,5]oxazocin-6-one
C22H31N3O4 (401.23144460000003)
(2S,3R)-8-[2-(1-hydroxycyclopentyl)ethynyl]-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-2-(methylaminomethyl)-3,4-dihydro-2H-pyrido[2,3-b][1,5]oxazocin-6-one
C22H31N3O4 (401.23144460000003)
(2S,3R)-8-[2-(1-hydroxycyclopentyl)ethynyl]-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-2-(methylaminomethyl)-3,4-dihydro-2H-pyrido[2,3-b][1,5]oxazocin-6-one
C22H31N3O4 (401.23144460000003)
2-[(2S,3R,6S)-3-[[(cyclohexylamino)-oxomethyl]amino]-2-(hydroxymethyl)-3,6-dihydro-2H-pyran-6-yl]-N-(phenylmethyl)acetamide
C22H31N3O4 (401.23144460000003)
2-[(2S,3S,6R)-3-[[(cyclohexylamino)-oxomethyl]amino]-2-(hydroxymethyl)-3,6-dihydro-2H-pyran-6-yl]-N-(phenylmethyl)acetamide
C22H31N3O4 (401.23144460000003)
(2R,3S)-8-[2-(1-hydroxycyclopentyl)ethynyl]-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-2-(methylaminomethyl)-3,4-dihydro-2H-pyrido[2,3-b][1,5]oxazocin-6-one
C22H31N3O4 (401.23144460000003)
(2S,3S)-8-[2-(1-hydroxycyclopentyl)ethynyl]-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-2-(methylaminomethyl)-3,4-dihydro-2H-pyrido[2,3-b][1,5]oxazocin-6-one
C22H31N3O4 (401.23144460000003)
2-[(2S,3R,6R)-3-[[(cyclohexylamino)-oxomethyl]amino]-2-(hydroxymethyl)-3,6-dihydro-2H-pyran-6-yl]-N-(phenylmethyl)acetamide
C22H31N3O4 (401.23144460000003)
2-[(2R,3S,6S)-3-[[(cyclohexylamino)-oxomethyl]amino]-2-(hydroxymethyl)-3,6-dihydro-2H-pyran-6-yl]-N-(phenylmethyl)acetamide
C22H31N3O4 (401.23144460000003)
2-[(2R,3S,6R)-3-[[(cyclohexylamino)-oxomethyl]amino]-2-(hydroxymethyl)-3,6-dihydro-2H-pyran-6-yl]-N-(phenylmethyl)acetamide
C22H31N3O4 (401.23144460000003)
2-[(2R,3R,6S)-3-[[(cyclohexylamino)-oxomethyl]amino]-2-(hydroxymethyl)-3,6-dihydro-2H-pyran-6-yl]-N-(phenylmethyl)acetamide
C22H31N3O4 (401.23144460000003)
2-[(2S,3S,6S)-3-[[(cyclohexylamino)-oxomethyl]amino]-2-(hydroxymethyl)-3,6-dihydro-2H-pyran-6-yl]-N-(phenylmethyl)acetamide
C22H31N3O4 (401.23144460000003)
2-[(2R,3R,6R)-3-[[(cyclohexylamino)-oxomethyl]amino]-2-(hydroxymethyl)-3,6-dihydro-2H-pyran-6-yl]-N-(phenylmethyl)acetamide
C22H31N3O4 (401.23144460000003)
Ro 64-6198
Ro 64-6198 is a potent, selective, nonpeptide, high-affinity, high cellular permeability and brain penetration N/OFQ receptor (NOP) agonist with an EC50 value of 25.6 nM. Ro 64-6198 is at least 100 times more selective for the NOP receptor over the classic opioid receptors. Ro 64-6198 can be used for stress and anxiety, addiction, neuropathic pain, cough, and anorexia[1][2].